Novartis AG (LTS:0QM7) OCF Margin %: 27.18% (As of Mar. 2026) — 12% Below Median


What is Novartis AG OCF Margin %?

Novartis AG LTS:0QM7 83 OCF Margin % is 27.18% as of Mar. 2026, which is 12% below its 10-year median of 30.98. GuruFocus rates LTS:0QM7 with a GF Score™ of 83/100. The stock has 7 warning signs investors should review. Among 956 Drug Manufacturers companies, Novartis AG ranks better than 94.77% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Novartis AG's Cash Flow from Operations for the three months ended in Mar. 2026 was CHF2,894.12 Mil. Novartis AG's Revenue for the three months ended in Mar. 2026 was CHF10,647.45 Mil. Therefore, Novartis AG's OCF Margin % for the quarter that ended in Mar. 2026 was 27.18%.

As of today, Novartis AG's current OCF Yield % is 6.37%.

The historical rank and industry rank for Novartis AG's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Novartis AG was 34.27%. The lowest was 23.21%. And the median was 30.98%.

LTS:0QM7's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.985
* Ranked among companies with meaningful OCF Margin % only.

Novartis AG OCF Margin % Related Terms

Novartis AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for Novartis AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG OCF Margin % Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.27 32.76 30.99 34.06 33.78

Novartis AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.76 44.92 45.77 16.33 27.18

Novartis AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Novartis AG's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=15255.854/45163.511
=33.78 %

Novartis AG's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=2894.115/10647.445
=27.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 27.18% mean?
Novartis AG (LTS:0QM7) has a OCF Margin % of 27.18% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Novartis AG and its competitors. This is 12% below median its historical median of 30.98. Over the past decade, Novartis AG's OCF Margin % has ranged from 23.21 to 34.27. According to the industry distribution chart, Novartis AG ranks #50 out of 956 companies in the Drug Manufacturers industry, placing it in the top 5.2%.
Is Novartis AG's OCF Margin % too high?
Novartis AG's current OCF Margin % of 27.18% is 12% below median its 10-year median of 30.98. Over the past 10 years, this metric has ranged from a low of 23.21 to a high of 34.27. The Drug Manufacturers industry median OCF Margin % is 9.99. Novartis AG's value of 27.18% is 172.2% above this industry median. Based on the distribution chart, Novartis AG ranks #50 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Novartis AG has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Novartis AG ranks #50 out of 956 companies for OCF Margin %. This places Novartis AG in the top 5% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Novartis AG's value of 27.18% is 172.2% above this benchmark. Historically, Novartis AG's own OCF Margin % has ranged from 23.21 to 34.27 over the past decade. While the company's 10-year median is 30.98 vs. the industry median of 9.99, Novartis AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novartis AG's current OCF Margin % of 27.18% is 172.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Novartis AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novartis AG's current OCF Margin % is 27.18%, which is 12% below median its own 10-year median of 30.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (LTS:0QM7) has a current OCF Margin % of 27.18%. The current OCF Margin % is 27.18%, which is 12% below median its 10-year median of 30.98 and 172.2% above the Drug Manufacturers industry median of 9.99. Novartis AG's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Novartis AG (LTS:0QM7), the current OCF Margin % is 27.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.